Skip to content

Drug interactions

Crizotinib + Dabigatran etexilate

Severity: Moderate

Crizotinib and Dabigatran etexilate: moderate interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Crizotinib can inhibit P-glycoprotein and may increase dabigatran absorption and exposure. This could heighten bleeding risk, particularly in patients with reduced renal function.

What this interaction means in plain words

Crizotinib and Dabigatran etexilate can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken.

Crizotinib belongs to Oncology; Dabigatran etexilate belongs to Cardiovascular.

Evidence level: Low

Why it happens

Inhibition of intestinal P-glycoprotein efflux of dabigatran etexilate.

What to do

Monitor for bleeding and check renal function regularly. Consider an alternative anticoagulant if renal function is significantly impaired.

What to ask your pharmacist

  • Should I take them at different times of day?
  • Does the dose of either medicine need to change?
  • Is there anything I should avoid, such as alcohol or certain foods, while on both?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Crizotinib and Dabigatran etexilate, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 7 days on the web. No card needed.

Frequently asked questions

Can I take Crizotinib with Dabigatran etexilate?

MediHelp rates the interaction as moderate. Crizotinib and Dabigatran etexilate can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken. Crizotinib can inhibit P-glycoprotein and may increase dabigatran absorption and exposure. This could heighten bleeding risk, particularly in patients with reduced renal function.

How serious is the interaction between Crizotinib and Dabigatran etexilate?

MediHelp rates it moderate, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Monitor for bleeding and check renal function regularly. Consider an alternative anticoagulant if renal function is significantly impaired.

What other medicines interact with Dabigatran etexilate?

MediHelp also lists interactions of Dabigatran etexilate with, for example, Defibrotide, Ketorolac, Mifepristone. The full list is on the Dabigatran etexilate page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in